Responses

This article has a correction. Please see:

Download PDFPDF

Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    Probiotics in IBD: mucosal and systemic routes of administration may promote similar effects.
    • Benoit Foligne, Researcher
    • Other Contributors:
      • Benoit Foligne, Corinne Grangette, and Bruno Pot.

    Dear Editor

    We read with considerable interest the paper by Sheil et al.[1] who reported the successful application of the subcutaneous route for the probiotic attenuation of colitis.

    We agree with the corresponding commentary of Ghosh et al.[2] regarding the need to study mechanisms underlying probiotic interactions. Recently, we further standardized a method to compare the anti-inflammatory pot...

    Show More
    Conflict of Interest:
    None declared.